￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Effect of Entrectinib/Luo Shengquan Combination Chemotherapy

2026-02-01 22:25:32

Check Details
Comparison of the efficacy of brigatinib/brigatinib (Embry) and similar targeted drugs

2026-02-01 22:25:32

Check Details
What are the purchasing channels for Acalabrutinib in China?

2026-02-01 22:25:32

Check Details
sevabertinib-Hyrnuo’s Chinese instruction manual

2026-02-01 22:25:32

Check Details
Fixed-duration venetoclax combination equivalent to continuous ibrutinib in head-to-head comparison in CLL

2026-02-01 22:25:32

Check Details
The efficacy of ruxolitinib tablets/Jiekewei in treating thrombocythemia

2026-02-01 22:25:32

Check Details
What are the indications for Clofazimine?

2026-02-01 22:25:32

Check Details
How effective is Sorafenib/Nexavar in treating kidney cancer?

2026-02-01 22:25:32

Check Details
Pemetinib/Dabotan FDA approval time

2026-02-01 22:25:32

Check Details
Erdafitinib/Bocco is safe and shows preliminary efficacy in F3T3 fusion+ glioma

2026-02-01 22:25:32

Check Details
Interactions between dacomitinib/dacomitinib (Dozerun) and food

2026-02-01 22:25:32

Check Details
What are the precautions for sevabertinib-Hyrnuo?

2026-02-01 22:25:32

Check Details
Category
相关知识